Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation (Q32054303)

6 July 2017

title

Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation (English)

1 reference

6 July 2017

1 reference

Taggart DP

1

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

The Annals of Thoracic Surgery

6 July 2017

published in

1 reference

6 July 2017

volume

71

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

238-242

1 reference

Respiratory dysfunction after uncomplicated cardiopulmonary bypass

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Effects of cardiopulmonary bypass temperature on pulmonary gas exchange after coronary artery operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Platelet-activating factor: a mediator for clinicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Variations of blood PAF-acether levels during coronary artery surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Platelet activating factor and thromboxane B2 production after cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Effects of a paf-receptor antagonist on hemodynamics during and after cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

Surgery with cardiopulmonary bypass and pulmonary inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

The effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901671-4

10.1016/S0003-4975(00)01671-4

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference